
ABPI calls for temporary export ban in effort to prevent shortages in case of no-deal Brexit
pharmafile | March 29, 2019 | News story | Medical Communications | ABPI, UK, brexit, drug shortages, export market
The Association of the British Pharmaceutical Industry (ABPI) has called for a temporary ban on exports as a means of preventing shortages in the event of a no-deal Brexit.
A plummeting pound could incentivise wholesalers to sell medicines overseas instead of in the UK, the ABPI said.
Despite measures aimed at preventing shortages of drugs in the UK, the ABPI claimed a drop in the value of the British pound could create a situation in which companies with export licenses would find it more lucrative to sell drugs inside the Eurozone, instead of in the UK.
The association thus wants the government to impose a temporary export ban on certain vital medicines as a means of curbing the ‘parallel market’. The Greek government took similar action during the financial crisis in 2013.
Nevertheless, wholesalers and pharmacists with export licenses make up a minority share of the UK medicines market.
However these companies could move enough medicines outside of the UK to cause problems for patients.
The news comes amid reports of shortages of some drugs caused by unofficial stockpiling by distributors.
A Department of Health and Social care spokesperson said: “We are aware of concerns raised about this issue and continue to work closely with the NHS, industry and the supply chain to ensure patients continue to access medicines in the same way they do now – whatever the EU exit outcome.”
Louis Goss
Related Content

Addenbrooke’s hospital offers first self-service digital eye test
Addenbrooke’s Hospital, Cambridge, has become the first in the UK to deploy a digital self-testing …

Digital Control Room, a major pharma provider, wins King’s Award for Enterprise
Buckingham Palace has announced that Digital Control Room, a software platform that monitors companies’ online …

Deadly cancers are being financially left behind, new research claims
New research has revealed that some of the UK’s most deadly and prevalent cancers receive …






